French pharma giant Sanofi SA has agreed to buy Synthorx Inc for US$2.5 billion, more than double the US biotech company’s last market price, accelerating its push into the field of cancer under new chief executive officer Paul Hudson.
Sanofi is to pay US$68 a share in cash for Synthorx, the companies said yesterday.
Shares of the unprofitable San Diego-based company closed at US$25.03 on Friday, having surged 40 percent last week.
The deal underscores the Paris-based drugmaker’s efforts to build its portfolio of innovative therapies in the fast-growing and lucrative cancer field.
Today, Hudson is to outline his pipeline and acquisition priorities, along with his plans for the consumer-health, diabetes and other units.
The purchase marks Sanofi’s first multibillion acquisition since early last year.
BANKING ON ONE MAN
Investors are counting on Hudson to fire up Sanofi’s research operations and step up the search for novel products to reduce its reliance on Dupixent, a standout medicine for severe eczema and asthma.
Hudson, the former pharma head at Novartis AG, is credited with launching key medicines at his previous job before becoming chief executive of Sanofi in September.
CANCER DRUGS
Synthorx’s main asset, known as THOR-707, is being explored across multiple types of solid tumors, and together with immune checkpoint inhibitors and other future combinations, the companies said.
The French drugmaker earlier this year said that it would accelerate 17 drug programs, almost half in cancer, and drop more than a dozen others under development.
Analysts at HSBC Holdings PLC in August wrote that more deals would be the fastest way to build up Sanofi’s stable of medicines and profile in cancer.
Sanofi shares have climbed about 11 percent since Hudson was named chief executive in June, closing at 83.56 euros on Friday.
The stock had declined almost 16 percent over the previous four years.
The Eurovision Song Contest has seen a surge in punter interest at the bookmakers, becoming a major betting event, experts said ahead of last night’s giant glamfest in Basel. “Eurovision has quietly become one of the biggest betting events of the year,” said Tomi Huttunen, senior manager of the Online Computer Finland (OCS) betting and casino platform. Betting sites have long been used to gauge which way voters might be leaning ahead of the world’s biggest televised live music event. However, bookmakers highlight a huge increase in engagement in recent years — and this year in particular. “We’ve already passed 2023’s total activity and
BIG BUCKS: Chairman Wei is expected to receive NT$34.12 million on a proposed NT$5 cash dividend plan, while the National Development Fund would get NT$8.27 billion Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday announced that its board of directors approved US$15.25 billion in capital appropriations for long-term expansion to meet growing demand. The funds are to be used for installing advanced technology and packaging capacity, expanding mature and specialty technology, and constructing fabs with facility systems, TSMC said in a statement. The board also approved a proposal to distribute a NT$5 cash dividend per share, based on first-quarter earnings per share of NT$13.94, it said. That surpasses the NT$4.50 dividend for the fourth quarter of last year. TSMC has said that while it is eager
‘IMMENSE SWAY’: The top 50 companies, based on market cap, shape everything from technology to consumer trends, advisory firm Visual Capitalist said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) was ranked the 10th-most valuable company globally this year, market information advisory firm Visual Capitalist said. TSMC sat on a market cap of about US$915 billion as of Monday last week, making it the 10th-most valuable company in the world and No. 1 in Asia, the publisher said in its “50 Most Valuable Companies in the World” list. Visual Capitalist described TSMC as the world’s largest dedicated semiconductor foundry operator that rolls out chips for major tech names such as US consumer electronics brand Apple Inc, and artificial intelligence (AI) chip designers Nvidia Corp and Advanced
Pegatron Corp (和碩), an iPhone assembler for Apple Inc, is to spend NT$5.64 billion (US$186.82 million) to acquire HTC Corp’s (宏達電) factories in Taoyuan and invest NT$578.57 million in its India subsidiary to expand manufacturing capacity, after its board approved the plans on Wednesday. The Taoyuan factories would expand production of consumer electronics, and communication and computing devices, while the India investment would boost production of communications devices and possibly automotive electronics later, a Pegatron official told the Taipei Times by telephone yesterday. Pegatron expects to complete the Taoyuan factory transaction in the third quarter, said the official, who declined to be
RSS